Skip to content

Clinical trials

Completed Ovarian Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Completed Country / region: South Korea Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20084
20092
20106
20111
20121
20132
20142
20153
20162
20172
20184
20195
20204
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Merck Sharp & Dohme LLC4
National Cancer Institute (NCI)3
Yonsei University3
Hoffmann-La Roche2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Seoul National University Hospital2
AGO Study Group1
Amgen1
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms47
Fallopian Tube Neoplasms10
Breast Neoplasms9
Stomach Neoplasms7
Colorectal Neoplasms6
Neoplasms6
Pancreatic Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Squamous Cell Carcinoma of Head and Neck4
Urinary Bladder Neoplasms4

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.